Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peroxiredoxin 4: a novel secreted mediator of cancer induced osteoclastogenesis.

Peroxiredoxin 4: a novel secreted mediator of cancer induced osteoclastogenesis. Cancer Lett. 2015 Jun 01; 361(2):262-70.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.